American Academy of Ophthalmology Meeting

CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at the American Academy of Ophthalmology meeting here.

CHICAGO — Teprotumumab, an IGF-1 receptor antagonist antibody, demonstrated improvement of double vision in patients with thyroid eye disease, according to a study presented here.

CHICAGO — The results of the integrated SAKURA program showed every-other-month dosing with intravitreal sirolimus improved ocular inflammation and vitreous haze in patients with non-infectious uveitis, according to a speaker here.

CHICAGO – At the American Academy of Ophthalmology meeting, Manjool Shah, MD, discusses improvements in surgical technology in the glaucoma space, particularly focusing on the Allergan Xen gel stent for patients with refractory disease.

CHICAGO — At the American Academy of Ophthalmology meeting, Alan Crandall, MD, of Moran Eye Center, Utah, discusses using new tools and techniques to address the burden of cataract surgery in underserved communities.

CHICAGO — Compared with Descemet’s membrane endothelial keratoplasty combined with cataract surgery, performing cataract surgery after Descemet’s membrane endothelial keratoplasty provides patients with better uncorrected distance visual acuity, no significant increase in endothelial cell loss, and additional beneficial outcomes, according to a speaker here.

CHICAGO — David S. Chin Yee, MD, discusses best practices in using the ForeseeHome device to monitor AMD patients' transition from dry to wet forms of the disease at the American Academy of Ophthalmology meeting here.

CHICAGO — At the American Academy of Ophthalmology meeting here, Ellie Chabi, MD, the therapeutic area head for glaucoma and neuroprotection and the lead for artificial intelligence programs within global biomedical science at Santen, discusses the initiation of two phase 3 clinical trials of omidenepag isopropyl for the treatment of glaucoma and ocular hypertension.

CHICAGO — At the American Academy of Ophthalmology meeting here, Laura M. Periman, MD, discusses the latest research with intense pulsed light therapy showing that it is effective in lowering inflammation in patients with dry eye disease.

CHICAGO — At the American Academy of Ophthalmology meeting here, Carl C. Awh, MD, discusses some of the advantages surgeons are learning about hypersonic vitrectomy with Bausch + Lomb’s Vitesse system in the first 100 retina surgery cases performed to date.